OPRM1 and Alzheimer disease: Our novel data suggest that DOR acts as an endogenous protector against AD injury by inhibiting BACE1 expression and activity, while the opposite is true for MOR, suggesting a possibility to develop a new strategy against AD by differentially targeting DOR and MOR.